# Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants

> **NCT03296982** · — · COMPLETED · sponsor: **Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Blood drawn by direct venipuncture
- **DRUG:** edoxaban
- **DRUG:** Enoxaparin
- **DRUG:** Saline sham

## Key facts

- **NCT ID:** NCT03296982
- **Lead sponsor:** Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03296982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03296982, "Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03296982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*